Skip to Content

Alibaba Health Information Technology Ltd ADR ALBBY

Morningstar Rating
$8.71 −0.09 (1.02%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ALBBY is trading at a 40% discount.
Price
$8.75
Fair Value
$69.70
Uncertainty
Very High
1-Star Price
$17.25
5-Star Price
$1.40
Economic Moat
Fbcrds
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALBBY is a good fit for your portfolio.

Trading Information

Previous Close Price
$8.80
Day Range
$8.718.72
52-Week Range
$8.0016.30
Bid/Ask
$8.41 / $8.98
Market Cap
$7.01 Bil
Volume/Avg
550 / 1,302

Key Statistics

Price/Earnings (Normalized)
40.12
Price/Sales
1.48
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.17%

Company Profile

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer”, although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Large Growth
Total Number of Employees
1,547

Competitors

Valuation

Metric
ALBBY
03690
01833
Price/Earnings (Normalized)
40.1260.08
Price/Book Value
2.753.141.01
Price/Sales
1.481.712.09
Price/Cash Flow
40.6414.05
Price/Earnings
ALBBY
03690
01833

Financial Strength

Metric
ALBBY
03690
01833
Quick Ratio
2.641.404.08
Current Ratio
3.011.754.26
Interest Coverage
96.237.81−64.28
Quick Ratio
ALBBY
03690
01833

Profitability

Metric
ALBBY
03690
01833
Return on Assets (Normalized)
5.00%3.06%−3.95%
Return on Equity (Normalized)
6.89%5.79%−5.08%
Return on Invested Capital (Normalized)
4.38%4.40%−6.70%
Return on Assets
ALBBY
03690
01833
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncBbd$18.3 Bil
RADLY
Raia Drogasil SA ADRMxjrdf$9.2 Bil
ALBHF
Alibaba Health Information Technology LtdGxhdmd$7.1 Bil
MSMKF
MatsukiyoCocokara & CoYwxpnb$6.9 Bil
WLCGF
Welcia Holdings Co LtdWvhcjcl$3.9 Bil
CLCGY
Clicks Group Ltd ADRLjxpyz$3.7 Bil
TSUSF
Tsuruha Holdings IncJhf$3.6 Bil
SGIPF
Sugi Holdings Co LtdGtwm$2.8 Bil
SHPPF
Redcare Pharmacy NVGckc$2.8 Bil

Sponsor Center